Free Trial

CareTrust REIT (NYSE:CTRE) Stock Price Target Lowered at UBS Group

CareTrust REIT logo with Real Estate background
Image from MarketBeat Media, LLC.

Key Points

  • UBS Group lowered CareTrust REIT’s price target from $48 to $44 while maintaining a “buy” rating, implying approximately 20.4% upside from the reported $36.54 share price.
  • Analyst sentiment remains positive overall: CareTrust REIT has a consensus “Moderate Buy” rating and an average price target of $43.92, supported by multiple buy and outperform ratings.
  • Institutional ownership is substantial at 87.77%, with major investors including BlackRock, Deutsche Bank, Bank of New York Mellon, UBS Asset Management, and Legal & General adding or initiating positions.
  • Five stocks we like better than CareTrust REIT.

CareTrust REIT (NYSE:CTRE - Get Free Report) had its target price reduced by equities research analysts at UBS Group from $48.00 to $44.00 in a note issued to investors on Tuesday, Benzinga reports. The firm currently has a "buy" rating on the stock. UBS Group's target price would suggest a potential upside of 20.43% from the stock's current price.

Several other equities research analysts also recently commented on the stock. Royal Bank Of Canada restated a "sector perform" rating and issued a $43.00 target price on shares of CareTrust REIT in a research note on Monday, October 5th. Weiss Ratings cut shares of CareTrust REIT from a "buy (b+)" rating to a "buy (b)" rating in a research report on Monday. Citigroup reissued a "market outperform" rating on shares of CareTrust REIT in a report on Tuesday. Huntington began coverage on shares of CareTrust REIT in a research report on Thursday, September 10th. They issued an "outperform" rating and a $44.00 price target on the stock. Finally, Cantor Fitzgerald boosted their price target on shares of CareTrust REIT from $42.00 to $43.00 and gave the company a "neutral" rating in a research report on Monday, August 10th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat, CareTrust REIT currently has an average rating of "Moderate Buy" and a consensus target price of $43.92.

Check Out Our Latest Stock Report on CareTrust REIT

CareTrust REIT Price Performance

Shares of CTRE stock traded down $0.10 during trading hours on Tuesday, hitting $36.54. The company had a trading volume of 1,973,187 shares, compared to its average volume of 2,546,499. CareTrust REIT has a 12 month low of $32.79 and a 12 month high of $43.62. The firm has a market capitalization of $8.63 billion, a price-to-earnings ratio of 22.98, a PEG ratio of 1.40 and a beta of 0.75. The firm's fifty day moving average is $38.52 and its 200 day moving average is $39.34. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.57 and a current ratio of 0.57.

CareTrust REIT (NYSE:CTRE - Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $0.51 EPS for the quarter, hitting the consensus estimate of $0.51. CareTrust REIT had a return on equity of 8.52% and a net margin of 62.19%. The business had revenue of $161.35 million during the quarter. CareTrust REIT has set its FY 2026 guidance at 2.030-2.060 EPS. On average, sell-side analysts predict that CareTrust REIT will post 2.07 EPS for the current fiscal year.

Institutional Trading of CareTrust REIT

Hedge funds and other institutional investors have recently made changes to their positions in the business. BlackRock Inc. acquired a new position in CareTrust REIT during the second quarter valued at approximately $1,643,290,000. Deutsche Bank AG bought a new stake in CareTrust REIT in the second quarter valued at approximately $143,963,000. Bank of New York Mellon Corp acquired a new stake in CareTrust REIT in the second quarter worth $102,162,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in CareTrust REIT by 35,170.9% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,411,896 shares of the company's stock worth $56,970,000 after purchasing an additional 1,407,893 shares during the period. Finally, Legal & General Group Plc acquired a new stake in CareTrust REIT in the second quarter worth $46,866,000. 87.77% of the stock is currently owned by institutional investors and hedge funds.

CareTrust REIT Company Profile

(Get Free Report)

CareTrust REIT, Inc is a real estate investment trust that owns, acquires, develops, and leases healthcare-related properties. Its portfolio is primarily focused on skilled nursing facilities, assisted living communities, and other post-acute care properties operated by third-party healthcare providers.

The company generally leases its properties under long-term agreements, including triple-net leases, under which tenants are typically responsible for property-level expenses such as taxes, insurance, and maintenance.

Further Reading

Analyst Recommendations for CareTrust REIT (NYSE:CTRE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CareTrust REIT Right Now?

Before you consider CareTrust REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CareTrust REIT wasn't on the list.

While CareTrust REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines